This website uses cookies to help us give you the best browsing experience. By continuing to use this portal, you agree to our use of this tool.
To learn more about how we use cookies and how to manage them please read our notice here.

Statement from the Executive Committee of EGS:
We stand with our colleagues in Ukraine and all of Ukraine’s people as they bravely face this difficult situation. Our thoughts are with them as we hope for a swift end to this conflict

Paving the Way to Better Glaucoma Care in Europe





Would you like to join the EGS?
Learn about the benefits and apply for membership here. It’s free.

EGS News

EGS Meetings

  • 16th EGS Congress
    1 – 4 June 2024 in Dublin, Ireland
  • All meetings at a glance

    Check out the EGS meeting calendar
  • 16th EGS Congress
    1 – 4 June 2024 in Dublin, Ireland
Education

  • Tip of the Month
    OCT Imaging of glaucoma patients at 6-month intervals may enhance progression detection while reducing the healthcare burden of more frequent testing
    September 2023
  • Clinical Paper of the Month
    Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial
    September 2023
  • Experimental Paper of the Month
    Repeat polymorphisms underlie top genetic risk loci for glaucoma and colorectal cancer
    September 2023
  • Tip of the Month
    OCT Imaging of glaucoma patients at 6-month intervals may enhance progression detection while reducing the healthcare burden of more frequent testing
    September 2023




back to top

X